Rahul Banerjee

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Rahul Banerjee
Dec 16, 2024, 17:18 | Blog
Rahul Banerjee: Antibody targets in smoldering multiple myeloma analyzed
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted the following on X: “Fascinating…
Dec 13, 2024, 15:39 | Societies
Best of 66th ASH Annual Meeting and Exposition
The 66th ASH Annual Meeting and Exposition was held from December 7-10, 2024, in San…
Dec 12, 2024, 13:11 | Societies
Highlights from Day 4 of 66th ASH Annual Meeting
The 66th ASH Annual Meeting and Exposition was held from December 7-10, 2024, in San…
Dec 11, 2024, 15:42 | Blog
Highlights from ASH 2024 by Rahul Banerjee
The 66th American Society of Hematology (ASH) Annual Meeting and Exposition was held from December…
Dec 10, 2024, 13:59 | Opinion
Rahul Banerjee: Safety run-in for Teclistamab and Lenalidomide maintenance after ASCT
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared a post on X: “MajesTEC-4!…
Dec 10, 2024, 13:33 | Blog
Rahul Banerjee: Robert Z. Orlowski presented updated IMROZ MRD Multiple Myeloma data
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted on X: "ASH24 well, this…
Dec 10, 2024, 10:40 | Insight
Highlights from ASH24 Day 2
The 66th ASH Annual Meeting and Exposition, is being held from December 7-10, 2024, in…
Dec 9, 2024, 16:20 | Blog
Rahul Banerjee: Thank you to all the patients with Multiple Myeloma who have contributed data to HealthTree Foundation Cure Hub
Rahul Banerjee, Assistant professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Dec 9, 2024, 13:25 | Blog
Rahul Banerjee: The US myeloma immunotherapy consortium has grown
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared a post on X: “The…
Dec 8, 2024, 06:11 | Societies
Highlights from Day 1 of ASH 2024 Annual Meeting and Exposition
The 66th American Society of Hematology (ASH) Annual Meeting and Exposition is being held from…
Dec 7, 2024, 03:09 | Insight
Greater than 17 years of training physicians to become academic BMT/CT experts
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Dec 5, 2024, 17:07 | Insight
Rahul Banerjee: T-Cell Redirection in AL Amyloidosis - Teclistamab's Success Ahead of ASH24
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared a post on X about…
Dec 5, 2024, 07:37 | Blog
Rahul Banerjee: Multiple Myeloma - Hematologic Toxicities and Advances in Quad Therapies
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Dec 3, 2024, 09:17 | Insight
UPEP 24 hour urine protein study is not necessary for response assessment in Myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared an article by…
Dec 1, 2024, 22:10 | Opinion
Mike Thompson: Myeloma/Plasma Cell Dyscrasia Draft Table Update
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, posted the following on X:…
Dec 1, 2024, 20:24 | Opinion
Vincent Rajkumar's Top 5 ASH24 myeloma abstracts
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared a post on X:…
Nov 12, 2024, 13:40 | Opinion
Rahul Banerjee: Ensuring the safety of CARs at the 4th Annual APAC Cell Therapy Conference
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Nov 4, 2024, 16:51 | Drugs
Rahul Banerjee: What Changes Once SQ Isatuximab Approved?
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Oct 26, 2024, 04:19 | Blog
Rahul Banerjee: Encouraging many of my Multiple Myeloma patients to try yoga, with “downward dog”
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Oct 19, 2024, 13:59 | Insight
Myeloma Paper of the Day, October 19th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Case series of patients…
Oct 18, 2024, 12:58 | Blog
Rahul Banerjee: Multicenter description of immune effector cell-associated enterocolitis as a novel toxicity of CAR T-cell therapy in multiple myeloma
Rahul Banerjee shared a post on X, about recent paper published in Blood Cancer Journal:…
Oct 16, 2024, 14:26 | Blog
Rahul Banerjee: An area where we need more research!
Rahul Banerjee shared a post by Nature Medicine on X, adding the following: “Relevant to…
Oct 4, 2024, 15:20 | Insight
Rahul Banerjee: Dexamethasone 40mg weekly in Multiple Myeloma induction
Rahul Banerjee shared his recent article on X: "Grateful to Blood Journal, co-authors, and SWOG…
Sep 30, 2024, 18:22 | Blog
Rahul Banerjee: Don’t say “atypical abnormal” unless it is
Rahul Banerjee shared a post on X: "IMS24 see the future of FISH reporting in Multiple…
Sep 26, 2024, 13:50 | Insight
Myeloma Paper of the Day, September 26th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Cool paper from Rahul Banerjee showing…
Sep 24, 2024, 11:34 | Blog
Rahul Banerjee: A picture worth a thousand words
Rahul Banerjee shared a post on X, about recent paper published in The Lancet Haematology:…
Sep 22, 2024, 04:52 | Blog
Rahul Banerjee: Why CAR-T recipients may appear to be at increased SPM risk?
Rahul Banerjee shared a post by The Cancer Letter on X, adding: "Thanks The Cancer Letter for the…
Sep 20, 2024, 14:07 | Blog
Rahul Banerjee: Congrats to Malin and the whole MSK team for this publication
Rahul Banerjee shared a post by Malin Hultcrantz, Associate Attending Physician, Assistant Professor at MSK…
Sep 12, 2024, 10:09 | Blog
Experts in multiple myeloma weigh the benefits and risks of second malignancies following CAR-T in Multiple Myeloma - Cancer Network
Rahul Banerjee shared a post by Cancer Network on X, adding: "Thanks Cancer Network,  The American Society for Transplantation and…
Sep 9, 2024, 09:26 | Blog
Rahul Banerjee: AURIGA results in IMS 2024 app
Rahul Banerjee shared a post on X: ''AURIGA results in the International Myeloma Society (IMS)…
Sep 1, 2024, 08:24 | Insight
Rahul Banerjee: Chronicle disparities in Relapsed or Refractory myeloma and why they matter
Rahul Banerjee shared on X: "Now in Blood Cancer Journal - our work to chronicle…
Aug 31, 2024, 16:59 | Blog
Rahul Banerjee: Supporting parents at ASH24
Rahul Banerjee, Assistant Professor at University of Washington, shared a post on X:   "Such a…
Aug 25, 2024, 09:29 | Insight
Rahul Banerjee: Fascinating Multiple Myeloma results of MajesTEC-1 in BCMA-exposed patients
Rahul Banerjee shared a post by Robert Z. Orlowski, Director of Myeloma Section at MD Anderson…
Aug 20, 2024, 14:29 | Blog
Rahul Banerjee: What's the best unifying term for the equivalent of bridging therapy but before apheresis?
Rahul Banerjee shared a poll on X: "Maybe more of a CAR-T consensus here than…
Aug 14, 2024, 10:29 | Insight
Rahul Banerjee: They say not all MRD negativity in myeloma is created equal
Rahul Banerjee shared on X: "They say not all MRD negativity in myeloma is created…
Aug 12, 2024, 22:03 | Blog
Rahul Banerjee: Timothy Schmid about whole-body MRI imaging in multiple myeloma at DAVA Heme
Rahul Banerjee, Assistant Professor at UW Medicine, shared on X: "DAVA Heme and now Timothy…
Aug 10, 2024, 13:10 | Blog
Rahul Banerjee: DAVAHeme Bermuda 2024
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post on X: "DAVAHeme Bermuda 2024.…
Aug 10, 2024, 12:42 | Blog
Rahul Banerjee: MajesTEC-1 analysis of response predictors in Multiple Myeloma by Cortes-Selva
Rahul Banerjee, Assistant Professor at University of Washington, shared a post on X:  "EXCELLENT Blood…
Aug 7, 2024, 01:13 | Insight
Rahul Banerjee's perspectives on approval of daratumumab and hyaluronidase plus VRd in MM
Oncology Data Advisor shared on X: "Did you hear about last week's approval of daratumumab…
Aug 4, 2024, 03:36 | Insight
Rahul Banerjee: Fascinating paper about time of day affecting CAR T-cell function
Rahul Banerjee, EASE (ECE Advocacy for Student Engagement) Director of Communications at Duke University Pratt…
Aug 2, 2024, 12:09 | Societies
Rahul Banerjee: ASH24 advice for everyone going through the ASH dash
Rahul Banerjee, Assistant Professor at UW Medicine, shared on X: "ASH24 advice for everyone going through the…
Aug 1, 2024, 08:32 | Insight
Rahul Banerjee: A 'CAR-E' - basically a care package for CAR T-cells as they start their first jobs
Rahul Banerjee, Assistant Professor at UW Medicine, shared a posts by Mohammad Rashidian, Assistant Professor, Dana-Farber Cancer Institute,…
Aug 1, 2024, 04:52 | Blog
Rahul Banerjee: Pleasure to be interviewed with Betsy O'Donnell about patient support group
Rahul Banerjee, Graduate Research Assistant at Duke University Pratt School of Engineering, shared CURE Today's…
Jul 29, 2024, 23:24 | Blog
Murali Janakiram: Rahul Banerjee nearly convinced me to wait for CAR T
Murali Janakiram, Associate Professor of Division of Hematological Malignancies at City of Hope, shared a…
Jul 29, 2024, 21:02 | Blog
GDUHEM summarized by Rahul Banerjee
GDUHEM (The Great Debates and Updates in Hematologic Malignancies) event took place in Los Angeles…
Jul 28, 2024, 15:35 | Insight
IgG replacement in myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, shared a paper by Rafael Fonseca et al on…
Jul 28, 2024, 13:30 | Blog
Rahul Banerjee: Looking forward to GDUHEM this weekend
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post on X: "Looking forward to discussing…
Jul 28, 2024, 12:28 | Insight
Ross Firestone: Antigen escape with BCMA-targeting therapies in multiple myeloma
Ross Firestone, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center, shared a post on X…
Jul 28, 2024, 08:13 | Blog
Rahul Banerjee: How different BCMA Treatment fare in Multiple myeloma by Matthew J Rees, Vincent Rajkumar et al
Rahul Banerjee, Assistant Professor at UW Medicine, shared on X: "Great Blood Cancer work by Matthew…
Jul 28, 2024, 07:55 | Blog
Luciano J Costa: MRD accelerating myeloma drug development
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Luciano J Costa, Professor of…
Jul 26, 2024, 00:11 | Blog
Rahul Banerjee's perspectives on the future of AI in oncology - Oncology Data Advisor
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Oncology Data Advisor on X,…
Jul 20, 2024, 21:30 | Insight
Rahul Banerjee: ARROW2 was here all this time and just got published in Blood Advances
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by, Robert Z. Orlowski, on X, adding:…
Jul 15, 2024, 21:23 | Blog
Rahul Banerjee: From PI to BYE, it is time to say goodbye to myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, shared on X: "At the HealthTree Foundation myeloma…
Jul 14, 2024, 22:08 | Blog
Rahul Banerjee: IL-18: magnifying glass, rejuvenating cream, and phone-a-friend all in one for T cells
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post on X: ''Fascinating MMsm work…
Jul 11, 2024, 14:47 | Insight
Flow cytometry to predict when to offer boosters to patients with multiple myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Bruno Paiva, Director Flow…
Jul 10, 2024, 00:26 | Blog
Myeloma podcast on BCMA-targeting bispeciifc antibodies - VJHemOnc
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) shared on X: "Did you know…
Jul 9, 2024, 06:35 | Blog
Rahul Banerjee: Nice analysis of Australia/New Zealand multiple myeloma with emphasis on CRAB vs SLiM
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “Now in The…
Jul 7, 2024, 14:46 | Opinion
Rahul Banerjee: Fascinating 3-way randomized trial of neuromuscular training
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “This is…
Jul 3, 2024, 02:35 | Insight
Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “Absolutely abscopal…
Jun 21, 2024, 08:50 | Blog
Rahul Banerjee: All I care about in myeloma is VGPR report
Rahul Banerjee, Assistant Professor at UW Medicine, shared Rafael Fonseca's post on X, adding:   …
Jun 13, 2024, 06:08 | Blog
Rahul Banerjee: So honored to have gotten Shaji Kumar’s wisdom on so many multiple myeloma questions
Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center, shared on X: "So honored to…
Jun 11, 2024, 11:27 | Blog
Rahul Banerjee: Excellent multiple myeloma work in Blood Cancer Journal
Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center, shared a post by Mattia D'Agostin,…
May 27, 2024, 04:03 | Opinion
Rahul Banerjee: My top 10 ASCO 24 multiple myeloma abstracts
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, shared…
May 21, 2024, 15:48 | Blog
Cancer Network - A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Cancer Network, on X: "So much fun…
May 21, 2024, 13:21 | Insight
Rahul Banerjee: Two-for-one with new MMsm articles in press in Transplantation and Cellular Therapy Journal
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, shared…
May 17, 2024, 13:44 | Drugs
Rahul Banerjee: Analysis of carfilzomib dosing in R/R myeloma
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, posted…
Apr 28, 2024, 13:30 | Blog
Rahul Banerjee: Now in CLML - The Netherlands study of myeloma MMsm income pre- and post-diagnosis
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, posted…
Feb 14, 2024, 19:34 | Blog
Robin Tuohy: We look forward to seeing our myeloma friends in the San Diego area at International IMF Regional Community Workshop!
Robin Tuohy, Vice-President of Support Groups at the International Myeloma Foundation, shared International Myeloma Foundation's…
Dec 17, 2023, 17:14 | Insight
Ajay Major: Critically important multiple myeloma study from ASH23
Quoting Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder…
Aug 13, 2023, 10:01 | Blog,Drugs
Rahul Banerjee: How do we standardize the standard of care for bortezomib (Velcade) in multiple myeloma?
Rahul Banarjee, Assistant Professor in the Division of Medical Oncology at the University of Washington,…
All: 70 Posts: 1 - 100
Special Coverage